Solutions

Dr. Steven Hatch carried Blessing Gea, 9, into the high-risk ward. Credit Daniel Berehulak for The New York Times

nytimes.com - by Sheri Fink - October 16, 2014

SUAKOKO, Liberia — The first time Dr. Steven Hatch suited up in protective gear at an Ebola treatment center, he was confronted with the weight of his decision to volunteer here. A patient, sweating and heavily soiled, had collapsed in a corridor. “Literally every surface of his body was covered in billions of particles of Ebola,” he recalled.

(READ COMPLETE ARTICLE)

NEW YORK TIMES                                                                  Oct 15, 2014
By DONALD G. McNEIL Jr.

A dummy depicting an Ebola patient was part of a C.D.C. training session for health care workers Wednesday in Anniston, Ala. Credit Erik S. Lesser/European Pressphoto Agency

FIERCE BOIOTECH RESEARCH                       Oct. 14, 2014
By Emily Mullin

Before the current Ebola outbreak, the virus had only appeared in Africa in fits and starts since its discovery in 1976, receding back into the jungle almost as quickly as it arrived. This relative rarity and the swiftness with which the disease kills its victims has, up until now, made Ebola an unattractive--not to mention daunting--prospect for drug developers. As a result, no approved drugs or vaccines against Ebola exist.

...the current situation in West Africa... has prompted the World Health Organization to call on international government agencies and the pharmaceutical industry to work together to speed up the development of promising therapies for experimental use for those most at risk of contracting the disease, which causes severe hemorrhagic fever.

Now, a handful of players are racing to get a treatment or vaccine to patients as quickly as possible, even though these drugs remain largely untested in humans.... 

Here is a list of organizations that are in the global spotlight right now with their investigational Ebola program

See full story and list

NBC NEWS                                                            OCT. 14, 2014

Facebook founder Mark Zuckerberg and his wife announced Tuesday they are donating $25 million to the U.S. Centers for Disease Control foundation to fight the Ebola crisis that has killed more than 4,440 people in west Africa.

"We need to get Ebola under control in the near term so that it doesn't spread further and become a long term global health crisis that we end up fighting for decades at large scale, like HIV or polio," Zuckerberg, who is worth $32 billion, said in a Facebook post. "We believe our grant is the quickest way to empower the CDC and the experts in this field to prevent this outcome."

The health agency has hundreds of staffers working on Ebola and has sent more than 100 experts to the virus zone — Liberia, Guinea, Sierra Leone and Nigeria. The CDC foundation collects funds for supplies, such as personal protective equipment, ready-to-eat meals, generators, vehicles and motorcycles, and thermal scanners to detect fever.

See full story